Literature DB >> 17923765

Overview of neonatal diabetes.

Julian P Hamilton-Shield1.   

Abstract

Diabetes developing within the first 6 months of life is rarely, if ever, caused by a classic type 1 diabetes-related autoimmune process. Currently, patients developing diabetes before 6 months of age are defined as having neonatal diabetes although this terminology possibly needs amending. Neonatal diabetes has a transient and permanent form and over 10 distinct genetic anomalies or mutations have been identified causing the disease. Transient neonatal diabetes can be caused by defects in the normal methylation pattern of an imprinted gene on chromosome 6 and by mutations in the 2 genes encoding the beta-cell ATP-sensitive potassium channel which is vital to normal glucose-stimulated insulin secretion. A genetic cause can be identified in over 90% of transient cases. Permanent neonatal diabetes can be caused by mutations in beta-cell transcription factors leading to abnormal pancreatic development often with other significant developmental anomalies, by defects in the glucose sensing, insulin secretory network and by accelerated Beta-cell destruction. About 30% of cases of permanent diabetes have yet to have a genetic cause identified.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923765     DOI: 10.1159/000109601

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  9 in total

1.  Treatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience.

Authors:  Stefano Passanisi; Tiziana Timpanaro; Donatella Lo Presti; Corrado Mammì; Manuela Caruso-Nicoletti
Journal:  Diabetes Technol Ther       Date:  2014-12       Impact factor: 6.118

2.  Functional analysis of Rfx6 and mutant variants associated with neonatal diabetes.

Authors:  Esther J Pearl; Zeina Jarikji; Marko E Horb
Journal:  Dev Biol       Date:  2011-01-04       Impact factor: 3.582

3.  The Krüppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in mice.

Authors:  Y Yang; B H-J Chang; V Yechoor; W Chen; L Li; M-J Tsai; L Chan
Journal:  Diabetologia       Date:  2011-07-23       Impact factor: 10.122

4.  Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.

Authors:  Maria Sara Remedi; Harley T Kurata; Alexis Scott; F Thomas Wunderlich; Eva Rother; Andre Kleinridders; Ailing Tong; Jens C Brüning; Joseph C Koster; Colin G Nichols
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

5.  Dual role of K ATP channel C-terminal motif in membrane targeting and metabolic regulation.

Authors:  Crystal F Kline; Harley T Kurata; Thomas J Hund; Shane R Cunha; Olha M Koval; Patrick J Wright; Matthew Christensen; Mark E Anderson; Colin G Nichols; Peter J Mohler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

6.  Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes.

Authors:  Maria Sara Remedi; Sophia E Agapova; Arpita K Vyas; Paul W Hruz; Colin G Nichols
Journal:  Diabetes       Date:  2011-08-03       Impact factor: 9.461

Review 7.  Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children.

Authors:  Vanessa Rodrigues Vilela; Any de Castro Ruiz Marques; Christiano Rodrigues Schamber; Roberto Barbosa Bazotte
Journal:  ScientificWorldJournal       Date:  2014-03-23

Review 8.  Recent Advances in Neonatal Diabetes.

Authors:  Amanda Dahl; Seema Kumar
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-12       Impact factor: 3.168

9.  Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the KATP channel.

Authors:  Maria S Remedi; Jonathan B Friedman; Colin G Nichols
Journal:  J Gen Physiol       Date:  2016-12-12       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.